Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-033520
Filing Date
2024-03-12
Accepted
2024-03-12 17:01:21
Documents
15
Period of Report
2024-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm248562d1_8ka.htm   iXBRL 8-K/A 40054
2 EXHIBIT-99.2 tm248562d1_ex99-2.htm EX-99.2 48077
  Complete submission text file 0001104659-24-033520.txt   279009

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20240308.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20240308_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20240308_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm248562d1_8ka_htm.xml XML 3612
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39294 | Film No.: 24743121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)